Technical Analysis for AXDX - Accelerate Diagnostics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
18.0 | -1.91% | -0.35 |
AXDX closed down 1.91 percent on Tuesday, August 20, 2019, on 80 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | Flat | Down | Up |
| See historical AXDX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 200 DMA | Bearish | 0.00% | |
| Fell Below 20 DMA | Bearish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| 20 DMA Support | Bullish | -1.91% | |
| NR7 | Range Contraction | -1.91% | |
| Crossed Above 200 DMA | Bullish | -1.59% | |
| Crossed Above 20 DMA | Bullish | -1.59% | |
| Calm After Storm | Range Contraction | -1.59% | |
| Bearish Engulfing | Bearish | 0.39% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/27/2019
- Sector: Healthcare
- Industry: Diagnostics & Research
Accelerate Diagnostics, Inc. engages in the research and development and commercialization of proprietary surface chemistry formulation and quantitative bio-analytical measurement instruments. The company is developing BACcel system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections. It also develops and licenses OptiChem surface coatings for use in microarraying components. The company was formerly known as Accelr8 Technology Corp. and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is based in Tucson, Arizona.
Technology Agilent Technologies Bacterial Infections
Technology Agilent Technologies Bacterial Infections
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more AXDX news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 24.75 |
| 52 Week Low | 10.23 |
| Average Volume | 187,221 |
| 200-Day Moving Average | 18.0221 |
| 50-Day Moving Average | 19.4728 |
| 20-Day Moving Average | 18.068 |
| 10-Day Moving Average | 17.795 |
| Average True Range | 0.926 |
| ADX | 34.23 |
| +DI | 10.7429 |
| -DI | 21.7271 |
| Chandelier Exit (Long, 3 ATRs ) | 16.9898 |
| Chandelier Exit (Short, 3 ATRs ) | 18.378 |
| Upper Bollinger Band | 19.7264 |
| Lower Bollinger Band | 16.4096 |
| Percent B (%b) | 0.48 |
| BandWidth | 18.357317 |
| MACD Line | -0.3807 |
| MACD Signal Line | -0.5401 |
| MACD Histogram | 0.1593 |
| Fundamentals | Value |
|---|---|
| Market Cap | 991.17 Million |
| Num Shares | 55.1 Million |
| EPS | -1.23 |
| Price-to-Earnings (P/E) Ratio | -14.63 |
| Price-to-Sales | 778.36 |
| Price-to-Book | 7.08 |
| PEG Ratio | -0.51 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 18.76 | ||||
| Resistance 3 (R3) | 18.83 | 18.65 | 18.63 | ||
| Resistance 2 (R2) | 18.65 | 18.46 | 18.61 | 18.59 | |
| Resistance 1 (R1) | 18.33 | 18.34 | 18.24 | 18.25 | 18.55 |
| Pivot Point | 18.14 | 18.14 | 18.10 | 18.11 | 18.14 |
| Support 1 (S1) | 17.82 | 17.95 | 17.73 | 17.75 | 17.45 |
| Support 2 (S2) | 17.64 | 17.83 | 17.60 | 17.41 | |
| Support 3 (S3) | 17.31 | 17.64 | 17.37 | ||
| Support 4 (S4) | 17.24 |
